Kovack Advisors’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$268K Sell
3,731
-510
-12% -$40.2K 0.01% 800
2025
Q4
$348K Buy
4,241
+456
+12% +$35.5K 0.02% 715
2025
Q3
$284K Sell
3,785
-584
-13% -$43.6K 0.03% 482
2025
Q2
$324K Buy
4,369
+1,144
+35% +$79.6K 0.03% 441
2025
Q1
$260K Sell
3,225
-177
-5% -$15.2K 0.03% 466
2024
Q4
$266K Buy
3,402
+175
+5% +$14.9K 0.03% 485
2024
Q3
$303K Sell
3,227
-414
-11% -$34.7K 0.03% 437
2024
Q2
$284K Buy
3,641
+150
+4% +$12.2K 0.03% 433
2024
Q1
$317K Sell
3,491
-877
-20% -$73K 0.04% 332
2023
Q4
$338K Sell
4,368
-1,503
-26% -$105K 0.04% 392
2023
Q3
$399K Buy
5,871
+2,053
+54% +$149K 0.06% 312
2023
Q2
$310K Buy
3,818
+621
+19% +$49.6K 0.04% 411
2023
Q1
$262K Buy
+3,197
New +$228K 0.04% 443

Other funds holding GEHC

Kovack Advisors's GEHC Position: Q1 2026 in Review

Kovack Advisors reduced its GE HealthCare (GEHC) stake by 12% in Q1 2026, selling an estimated $40.2K and leaving 3,731 shares worth $268K. The position accounts for 0.01% of the portfolio, ranked #800.

Kovack Advisors first reported a position in GEHC in Q1 2023 and has held it in 13 quarters since. The position peaked at $399K in Q3 2023. 1,263 funds tracked by Wall St. Rank hold GEHC as of Q1 2026.

  • Kovack Advisors held 3,731 shares of GE HealthCare worth $268K as of Q1 2026.
  • Kovack Advisors sold 510 GE HealthCare shares in Q1 2026, an estimated $40.2K.
  • GE HealthCare made up 0.01% of Kovack Advisors's portfolio in Q1 2026, its #800 holding.
  • Kovack Advisors first reported a position in GE HealthCare in Q1 2023 and has held it in 13 quarters since.
  • Kovack Advisors's GE HealthCare position peaked at $399K in Q3 2023.
  • 1,263 funds tracked by Wall St. Rank held GE HealthCare as of Q1 2026.

Based on Kovack Advisors's 13F filing for Q1 2026, filed 13 May 2026.